SHG:688319 - Chengdu Olymvax Biopharmaceuticals Inc

Chengdu Olymvax Biopharmaceuti
Sector: Health Care, Industry: Biotechnology

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts

Balance Sheet Cash Flow Income Statement Key Ratios Personalized

Show %	2017 Q4	2018 Q4	2019 Q1	2019 Q3	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	Graph
Total Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	377.74M 6.5%	404.79M 7.2%	487.15M 20.3%	477.25M -2.0%	550.74M 15.4%	573.16M 4.1%	547.48M -4.5%	560.82M 2.4%	547.97M -2.3%	529M -3.5%	496.12M -6.2%	500.05M 0.8%
Cost of Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	21.12M 26.9%	25.39M 20.2%	29.58M 16.5%	29.97M 1.3%	34.73M 15.9%	35.53M 2.3%	39.06M 9.9%	43.32M 10.9%	37.83M -12.7%	36.95M -2.3%	32M -13.4%	30.2M -5.6%
Gross Profit	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	356.61M 5.5%	379.39M 6.4%	457.57M 20.6%	447.28M -2.2%	516.01M 15.4%	537.63M 4.2%	508.42M -5.4%	517.5M 1.8%	510.14M -1.4%	492.06M -3.5%	464.12M -5.7%	469.85M 1.2%
Total Expenses	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	306.59M 5.7%	325.67M 6.2%	377.65M 16.0%	395.88M 4.8%	439.41M 11.0%	482.35M 9.8%	487M 1.0%	488.53M 0.3%	488.39M 0.0%	496.01M 1.6%	464.01M -6.5%	507.16M 9.3%
Operating Expense	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	285.47M 4.4%	300.28M 5.2%	348.07M 15.9%	365.91M 5.1%	404.68M 10.6%	446.82M 10.4%	447.94M 0.3%	445.21M -0.6%	450.56M 1.2%	459.06M 1.9%	432.01M -5.9%	476.96M 10.4%
Operating Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	71.15M 10.3%	79.12M 11.2%	109.5M 38.4%	81.37M -25.7%	111.33M 36.8%	90.81M -18.4%	60.48M -33.4%	72.29M 19.5%	59.59M -17.6%	33M -44.6%	32.11M -2.7%	-7.11M -
Net Income (Cont Operations)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	65.46M 20.2%	-	107.96M -	-	96.65M -	-	26.58M -	-	21.98M -	-	11.44M -	-
Net Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	65.46M 20.2%	77.68M 18.7%	107.96M 39.0%	80.72M -25.2%	96.65M 19.7%	70.47M -27.1%	26.58M -62.3%	37.24M 40.1%	24.08M -35.3%	16.68M -30.7%	17.56M 5.2%	-12.3M -
Basic EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	0.179 20.1%	0.205 14.4%	0.28 36.6%	0.208 -26.0%	0.241 16.0%	0.174 -27.7%	0.066 -62.3%	0.092 40.1%	0.059 -35.4%	0.041 -30.6%	0.043 5.1%	-0.03 -
Diluted EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	0.179 20.1%	0.205 14.4%	0.28 36.6%	0.208 -26.0%	0.241 16.0%	0.174 -27.7%	0.066 -62.3%	0.092 40.1%	0.059 -35.4%	0.041 -30.6%	0.043 5.1%	-0.03 -